Loading...
Bio-Gene Technology Limited
BGT.AX•ASX
Healthcare
Biotechnology
A$0.02
A$0.00(0.00%)
Bio-Gene Technology Limited (BGT.AX) Financial Performance & Income Statement Overview
Review Bio-Gene Technology Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-96.92%
↓ 96.92%
Operating Income Growth
3.76%
↑ 3.76%
Net Income Growth
22.18%
↑ 22.18%
Operating Cash Flow Growth
15.94%
↑ 15.94%
Operating Margin
747196.09%
↑ 747196.09%
Gross Margin
128484.37%
↑ 128484.37%
Net Profit Margin
543616.78%
↑ 543616.78%
ROE
-114.86%
↓ 114.86%
ROIC
-236.31%
↓ 236.31%
Bio-Gene Technology Limited (BGT.AX) Income Statement & Financial Overview
Review Bio-Gene Technology Limited's (BGT.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | -$435.00 | $18755.00 | $149232.00 |
| Cost of Revenue | $428947.00 | $129525.00 | $190244.00 | $290437.00 |
| Gross Profit | -$428947.00 | -$129960.00 | -$171489.00 | -$141205.00 |
| Gross Profit Ratio | $0.00 | $298.76 | -$9.14 | -$0.95 |
| R&D Expenses | $540416.00 | $353346.00 | $717065.00 | $757229.00 |
| SG&A Expenses | $552879.00 | $1.24M | $445848.00 | $669401.00 |
| Operating Expenses | $1.09M | $1.60M | $1.16M | $1.43M |
| Total Costs & Expenses | $1.52M | $1.73M | $1.35M | $1.72M |
| Interest Income | $0.00 | $0.00 | $46776.00 | $42183.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $18223.00 | $16225.00 | $22156.00 | $22459.00 |
| EBITDA | -$1.49M | -$924004.00 | -$1.53M | -$1.50M |
| EBITDA Ratio | $0.00 | $2124.15 | -$81.78 | -$10.36 |
| Operating Income | -$1.52M | -$1.73M | -$1.33M | -$1.57M |
| Operating Income Ratio | $0.00 | $3972.55 | -$71.15 | -$10.51 |
| Other Income/Expenses (Net) | $21835.00 | $828100.00 | -$279003.00 | $42438.00 |
| Income Before Tax | -$1.50M | -$899961.00 | -$1.51M | -$1.53M |
| Income Before Tax Ratio | $0.00 | $2068.88 | -$80.47 | -$10.22 |
| Income Tax Expense | -$35635.00 | $0.00 | -$104187.00 | -$400000.00 |
| Net Income | -$1.46M | -$899961.00 | -$1.51M | -$1.13M |
| Net Income Ratio | $0.00 | $2068.88 | -$80.47 | -$7.54 |
| EPS | -$0.007 | -$0.005 | -$0.008 | -$0.006 |
| Diluted EPS | -$0.007 | -$0.005 | -$0.008 | -$0.006 |
| Weighted Avg Shares Outstanding | $200.65M | $190.63M | $179.67M | $177.91M |
| Weighted Avg Shares Outstanding (Diluted) | $200.65M | $191.97M | $179.67M | $177.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan